Outpatient Microdose Induction with Transdermal Buprenorphine: A Case Series.  Menard S, Jhawar A.  Healthcare (Basel). 2022 Jul 14;10(7):1307. doi: 10.3390/healthcare10071307. PMID: 35885833; PMCID: PMC9317019. https://www.ncbi.nlm.nih…

The Naloxone Component of Buprenorphine/Naloxone: Discouraging Misuse, but at What Cost?  Gregg J, Hartley J, Lawrence D, Risser A, Blazes C.  J Addict Med. 2022 Aug 1. doi: 10.1097/ADM.0000000000001030. Epub ahead of print. PMID: 359139…

Treatment retention in opioid agonist therapy: comparison of methadone versus buprenorphine/naloxone by analysis of daily-witnessed dispensed medication in a Canadian Province. Sadek J, Saunders J.  BMC Psychiatry. 2022 Jul 30;22(1):516. doi…

Development of an intravenous low-dose buprenorphine initiation protocol.  Jablonski LA, Bodnar AR, Stewart RW.  Drug Alcohol Depend. 2022 Aug 1;237:109541. doi: 10.1016/j.drugalcdep.2022.109541. Epub 2022 Jun 20. PMID: 35753281. Abstra…

Depot buprenorphine: Safe and effective for clients in jails and prisons? There are barriers to receiving opioid use disorder medications, such as buprenorphine, for individuals in criminal justice settings like jails and prisons. These include lim…

Treatment Choices: Buprenorphine Exchange Supplies, UK. Third edition. oD https://www.exchangesupplies.org/pdf/P802.pdf